Eyenovia, Inc. (NASDAQ:EYEN) will be hosting a conference call at 4:30 PM eastern time on 12th August 2020, to discuss its 2Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.eyenoviabio.com
Earnings Expectation
Eyenovia, Inc. a clinical stage biopharmaceutical company, is expected to report second quarter earnings results, after market close, on Wednesday 12th August 2020. Analysts polled by Thomson Reuters anticipate second quarter loss of $ 0.25 per share. Looking ahead, the full year loss are expected at $ 1.08 per share.
Eyenovia, Inc., a clinical stage ophthalmic biopharmaceutical company, engages in developing a pipeline of microdose therapeutics in the United States. It is developing MicroProst, which is in Phase III clinical trials for the treatment of chronic angle closure glaucoma, open angle glaucoma, and ocular hypertension; MicroStat, which has completed Phase III clinical trials for the treatment of mydriasis; MicroTears for the treatment of hyperemia, pruritis, and dry eye; and MicroPine for the treatment of progressive myopia. The company was formerly known as PGP Holdings V, Inc.
